| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $500.2M | +73.7% |
| Cost of Revenue | $20.9M | -6.8% |
| R&D Expense | $29.6M | +7.1% |
| SG&A Expense | $30.3M | +15.1% |
| Operating Income | $31.8M | +161.1% |
| Pre-tax Income | $34.0M | +167.1% |
| Income Tax | $1.8M | +218.7% |
| Net Income | $32.2M | +162.7% |
| EPS (Basic) | $0.92 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.1M | +169.0% |
| Accounts Receivable | $61.3M | +189.6% |
| Current Assets | $171.8M | +148.1% |
| Total Assets | $210.5M | +89.8% |
| Current Liabilities | $72.6M | +142.6% |
| Total Liabilities | $75.2M | +150.4% |
| Stockholders' Equity | $135.4M | +67.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.6M | +2453.8% |
| Investing Cash Flow | -$4.1M | -144.0% |
| Financing Cash Flow | $1.7M | +195.8% |
| +159.7% |
| EPS (Diluted) | $0.88 | +157.1% |